D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

This paper adds to existing evidence about the cost of increasing regulation in foregone economic growth and highlights the issue for policymakers. The effects of growing regulation on the pace of ...

Researchers from London's Moorfields Eye Hospital, biotech firm MeiraGTx and University College London have demonstrated that ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)[1] and OXB,[2] today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

The cell and gene therapies in rare disorders market is expected to grow at a significantly high rate during the forecast period (2025–2034) and main ...

Trump has always been a wrecking ball, but now that he’s pummeling Big Tech’s perceived enemies, he’s become a hero to a ...

Inc. (NASDAQ: BLUE) ("bluebird") today announced that it has entered into a definitive agreement to be acquired by funds managed by global investment firms Carlyle (NASDAQ: CG) and SK Capital Partners ...

USDA Animal and Plant Health Inspection Service (APHIS) announced on January 23, 2025, that it is reinstating its legacy ...

A security vulnerability in the Indian Post Office portal has exposed sensitive Know Your Customer (KYC) data of thousands of users through an Insecure Direct Object Reference (IDOR) attack vector.

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...

The UK government’s AI Opportunities Action Plan promises billions in investment to position Britain as a leader in ...

NYU Langone has built an LLM research companion and medical advisor, and is pioneering what it calls AI-driven “precision medical education." ...